Drugs · acquisition-cost intelligence
LIKMEZ
Metronidazole Oral· ingredient metronidazoleAntiinfectives and antiseptics for local oral treatment· METRONIDAZOLE 100 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$2.61
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other metronidazole products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| metronidazole | $0.09229 | −$2.52 |
| metronidazole vaginal | $0.14703 | −$2.46 |
| Metronidazole | $0.29266 | −$2.32 |
| METRONIDAZOLE | $0.35391 | −$2.25 |
| metronidazole | $0.68397 | −$1.92 |
| metronidazole | $1.85 | −$0.75450 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.